Department of Chemical Engineering, University of California, Santa Barbara, CA 93106, USA.
Center for Bioengineering, University of California, Santa Barbara, CA 93106, USA.
J Control Release. 2019 Mar 10;297:71-78. doi: 10.1016/j.jconrel.2019.01.037. Epub 2019 Jan 29.
Biologics have limited permeability across the intestine and are prone to degradation in the acidic-proteolytic milieu of the gastrointestinal tract, leading to poor oral bioavailability. Iontophoresis is a promising technology that can substantially improve transport of drugs across biological barriers and has been particularly explored for skin. In this study, we investigated whether iontophoresis across the intestine can be utilized to improve oral insulin transport. Application of electric current to intestinal cells resulted in opening of the tight junctions in vitro and a consequent about 3-fold improvement in paracellular transport of insulin. When evaluated in vivo using insulin-loaded mucoadhesive patches, iontophoresis produced profound hypoglycemia (63% blood glucose drop in 3 h) without damaging the intestinal tissue and the efficacy depended on insulin dose and current density. This study presents a proof of principle for intestinal iontophoresis as a novel method for oral protein delivery.
生物制剂在肠道中的通透性有限,并且容易在胃肠道的酸性蛋白水解环境中降解,从而导致口服生物利用度差。离子电渗是一种很有前途的技术,可以显著改善药物在生物屏障中的传输,并且已经特别针对皮肤进行了研究。在这项研究中,我们研究了跨肠离子电渗是否可用于改善口服胰岛素的转运。电流施加到肠细胞会导致紧密连接在体外打开,从而使胰岛素的细胞旁转运增加约 3 倍。当使用负载胰岛素的粘膜粘附贴片在体内进行评估时,离子电渗会产生明显的低血糖作用(3 小时内血糖下降 63%),而不会损害肠道组织,其功效取决于胰岛素剂量和电流密度。这项研究证明了肠道离子电渗是一种用于口服蛋白传递的新型方法。